TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
SAB Biotherapeutics has developed novel SAB-176, an investigational drug for post-exposure prophylaxis of influenza A and B in high-risk patients, including those with resistant strains of the virus....
Sun Pharmaceutical Industries dicovered CEQUA®, a novel therapy for the treatment of dry eye disease....
Eli Lilly Japan and Mitsubishi Tanabe Pharma Corporation has introduced “Mounjaro® subcutaneous injection 2.5 mg / 5 mg ATEOS®”....
Regenxbio discovered novel RGX-202, a one-time gene therapy candidate for the treatment of Duchenne muscular dystrophy. RGX-202 is designed to deliver a novel microdystrophin transgene containing functional elements of the C-terminal (CT) domain found in naturally occurring dystrophin....
The Janssen Pharmaceutical Companies of Johnson & Johnson discovered first-of-its-kind ERLEADA® (apalutamide) for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC)....
Moderna and Merck developed mRNA-4157/V940, an investigational personalised mRNA cancer vaccine in combination with KEYTRUDA® (pembrolizumab) for the treatment of high-risk melanoma following complete resection. The combination of mRNA-4157/V940 with KEYTRUDA demonstrated efficacy...
Apellis Pharmaceuticals developed SYFOVRE™ (pegcetacoplan injection) for the treatment of secondary age-related macular degeneration (AMD). SYFOVRE™ (pegcetacoplan injection) is the only therapy approved for geographic atrophy (GA). By targeting C3, pegcetacoplan is designed to provide comprehensive control...
Abbisko Therapeutics discovered novel CSF-1R inhibitor Pimicotinib（ABSK021) for the treatment of tenosynovial giant cell tumour (TGCT) patients not responding to surgery. Pimicotinib is the first new generation CSF-1R drug candidate in the world. It is a novel, oral, highly selective and highly potent small molecule inhibitor of CSF-1R. Several studies have shown...
Loxo@Lilly the oncology unit of Eli Lilly and Company discovered novel Jaypirca™ (pirtobrutinib, 100 mg & 50 mg tablets) for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL). Jaypirca is the first and only BTK inhibitor specifically discovered for patients with mantle cell lymphoma...
Innovent Biologics, Inc. Discovered novel IBI351/GFH925(KRASG12C Inhibitor) as monotherapy for the patients previously treated with advanced non-small cell lung cancer. It is applicable for patients with KRASG12C mutation who have received at least one prior line of systemic therapy....
